Showing results (81-90 of 197) with videos related to

Sort By:
Pageof 20
Cancer Treatment Reports|February 1, 1980
Burkitt's lymphoma: tumor lysis following malignant hyperthermiaR P Suer, W B Fisher, R W Pearson, et al.
American Journal of Clinical Pathology|May 1, 1994
Anticardiolipin wet workshop report. Fifth International Symposium on antiphospholipid antibodiesE N Harris, S Pierangeli, D Birch
Thrombosis Research|December 1, 2001
The evaluation of clotting times in the laboratory detection of lupus anticoagulantsE M Jacobsen, L Barna-Cler, J M Taylor, et al.
American Journal of Clinical Pathology|December 1, 1984
Proficiency testing and standardization of prothrombin time: effect of thromboplastin, instrumentation, and plasmaA M van den Besselaar, B L Evatt, D R Brogan, et al.
Arthritis and Rheumatism|January 27, 1999
Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodiesM Ieko, K Ichikawa, D A Triplett, et al.
Thrombosis and Haemostasis|January 12, 2001
Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic testsM Galli, J Dlott, F Norbis, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1990
Evaluation of APTT reagent sensitivity to factor IX and factor IX assay performance. Results from the College of American Pathologists Survey ProgramJ T Brandt, C F Arkin, E G Bovill, et al.
Archives of Pathology & Laboratory Medicine|September 1, 1992
Factors affecting the performance of factor VIII coagulant activity assays. Results of proficiency surveys of the College of American PathologistsC F Arkin, E G Bovill, J T Brandt, et al.
American Journal of Clinical Pathology|November 1, 1994
Effects of repeated freeze-thaw cycles on anticardiolipin antibody immunoreactivityR L Brey, S A Cote, D L McGlasson, et al.
Pageof 20